MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products
15 janv. 2018 07h00 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that further to its press release dated August 22, 2017, it has...
MPX Enters Into Management and Option Agreements With Production Facility and Second Dispensary in Maryland
08 janv. 2018 07h00 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its indirect wholly-owned subsidiary,...
MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement
04 janv. 2018 16h13 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) would like comment on the memo issued today from the office of Jeffrey Sessions,...
MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees
03 janv. 2018 17h00 HE
|
MPX Bioceutical Corporation
TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that Beth Stavola, Chief Operating Officer, and a Director of...
MPX Closes Oversubscribed Private Placement Offering of $26.5 Million
22 déc. 2017 17h02 HE
|
MPX Bioceutical Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- (CSE:MPX) (OTC:MPXEF) MPX Bioceutical Corporation (the...
MPX Bioceutical Corporation Provides Update on Private Placement
19 déc. 2017 19h59 HE
|
MPX Bioceutical Corporation
TORONTO, Dec. 19, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to provide this corporate update concerning its previously announced...
MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland
12 déc. 2017 07h00 HE
|
MPX Bioceutical Corporation
TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its indirect wholly-owned subsidiary,...
MPX Bioceutical Receives Both Municipal and State Approval for GreenMart of Nevada NLV License Transfer
11 déc. 2017 07h00 HE
|
MPX Bioceutical Corporation
TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its wholly-owned U.S. subsidiary, CGX...
MPX Bioceutical Corporation Announces $25 Million Private Placement of Units
30 nov. 2017 17h07 HE
|
MPX Bioceutical Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) (the “Company” or “MPX”) announced today that it has...
Mpx Reports Q2 Fiscal 2018 Results
30 nov. 2017 07h00 HE
|
MPX Bioceutical Corporation
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- (CSE: MPX) (OTCQB:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) reports financial results for its second quarter...